Prognostic Estimation of Advanced Heart Failure With Low Left Ventricular Ejection Fraction and Wide QRS Interval

다국어 초록 (Multilingual Abstract)

Background and Objectives: Cardiac resynchronization therapy (CRT) has been known to improve the outcome of advanced heart failure (HF) but is still underutilized in clinical practice. We investigated the prognosis of patients with advanced HF who were suitable for CRT but were treated with conventional strategies. We also developed a risk model to predict mortality to improve the facilitation of CRT.
Subjects and Methods: Patients with symptomatic HF with left ventricular ejection fraction ≤35% and QRS interval >120 ms were con-secutively enrolled at cardiovascular hospital. After excluding those patients who had received device therapy, 239 patients (160 males,mean 67±11 years) were eventually recruited.
Results: During a follow-up of 308±236 days, 56 (23%) patients died. Prior stroke, heart rate >90 bpm, serum Na ≤135 mEq/L, and se-rum creatinine ≥1.5 mg/dL were identified as independent factors using Cox proportional hazards regression. Based on the risk model,points were assigned to each of the risk factors proportional to the regression coefficient, and patients were stratified into three risk groups: low- (0), intermediate- (1-5), and high-risk (>5 points). The 2-year mortality rates of each risk group were 5, 31, and 64 percent, re-spectively. The C statistic of the risk model was 0.78, and the model was validated in a cohort from a different institution where the C sta-tistic was 0.80.
Conclusion: The mortality of patients with advanced HF who were managed conventionally was effectively stratified using a risk model. It may be useful for clinicians to be more proactive about adopting CRT to improve patient prognosis.

참고문헌 (Reference)

1 O’Connor CM, "Triage after hospitalization with advanced heart failure: the ESCAPE (Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness) risk model and discharge score" 55 : 872-878, 2010

2 Mosterd A, "The prognosis of heart failure in the general population: the Rotterdam Study" 22 : 1318-1327, 2001

3 Levy WC, "The Seattle Heart Failure Model: prediction of survival in heart failure" 113 : 1424-1433, 2006

4 Cleland JG, "The CARE-HF Study (CArdiac REsynchronisation in Heart Failure Study): rationale, design and endpoints" 3 : 481-489, 2001

5 Patel JJ, "Tachycardia-induced heart failure" 11 : 50-52, 2007

6 Touzé E, "Risk of myocardial infarction and vascular death after transient ischemic attack and ischemic stroke: a systematic review and meta-analysis" 36 : 2748-2755, 2005

7 McAlister FA, "Renal insufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort study" 109 : 1004-1009, 2004

8 Iuliano S, "QRS duration and mortality in patients with congestive heart failure" 143 : 1085-1091, 2002

9 Thohan V, "Prognostic implications of echocardiography in advanced heart failure" 19 : 238-249, 2004

10 Lee DS, "Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model" 290 : 2581-2587, 2003

11 Hays AG, "Left ventricular systolic dysfunction and the risk of ischemic stroke in a multiethnic population" 37 : 1715-1719, 2006

12 Sarnak MJ, "Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention" 108 : 2154-2169, 2003

13 Van Veldhuisen DJ, "Implementation of device therapy (cardiac resynchronization therapy and implantable cardioverter defibrillator) for patients with heart failure in Europe: changes from 2004 to 2008" 11 : 1143-1151, 2009

14 Oren RM, "Hyponatremia in congestive heart failure" 95 (95): B2-B7, 2005

15 Fonarow GC, "Heart failure care in the outpatient cardiology practice setting: findings from IMPROVE HF" 1 : 98-106, 2008

16 Rassi A Jr, "Development and validation of a risk score for predicting death in Chagas’ heart disease" 355 : 799-808, 2006

17 Feldman AM, "Cost effectiveness of cardiac resynchronization therapy in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Trial" 46 : 2311-2321, 2005

18 Adams RJ, "Coronary risk evaluation in patients with transient ischemic attack and ischemic stroke: a scientific statement for healthcare professionals from the Stroke Council and the Council on Clinical Cardiology of the American Heart Association/ American Stroke Association" 108 : 1278-1290, 2003

19 Bristow MR, "Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure" 350 : 2140-2150, 2004

20 Curtis AB, "Cardiac resynchronization therapy utilization for heart failure: findings from IMPROVE HF" 158 : 956-964, 2009

21 Upadhyay GA, "Cardiac resynchronization in patients with atrial fibrillation: a meta-analysis of prospective cohort studies" 52 : 1239-1246, 2008

22 Jarcho JA, "Biventricular pacing" 355 : 288-, 2006

23 Bardy GH, "Amiodarone or an implantable cardioverter- defibrillator for congestive heart failure" 352 : 225-237, 2005

24 Epstein AE, "ACC/AHA/HRS 2008 guidelines for device-based therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons" 51 : e1-e62, 2008

25 Jessup M, "2009 focused update: ACCF/ AHA guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation/ American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation" 119 : 1977-2016, 2009